wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36896567-E5B58C9E-64B3-4664-9BE1-DC344CAEC76A
Q36896567-E5B58C9E-64B3-4664-9BE1-DC344CAEC76A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36896567-E5B58C9E-64B3-4664-9BE1-DC344CAEC76A
Review of S100A9 biology and its role in cancer.
P2860
Q36896567-E5B58C9E-64B3-4664-9BE1-DC344CAEC76A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36896567-E5B58C9E-64B3-4664-9BE1-DC344CAEC76A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8aa6fa5d60769ea96f969c6675aeda89bc46b9a8
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.